Nibla, Baby Boy .

HRN: 28-53-54  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
02/13/2026
02/20/2026
IV
55mg
Q24h
Neonatal Sepsis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: